Qihe Biotech
Suzhou
About Qihe Biotech
Qihe Biotech focuses on designing and developing new genome editing tools that are programmable and autonomous. The business focuses on creating innovative, autonomous, and controllable genome editing technology and investigates its potential applications in biological breeding and other domains, offering sophisticated genomic solutions to industrial users.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $57.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: qi-biodesign.com
- Phone: +86 010-69733448
Industries & Categories
AgTech, Biotechnology, Genetics
Canonical: https://fsome.com/organization/qihe-biotech-56262 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.